Efficacy and safety of a quadruple combination Combivir + abacavir + efavirenz regimen in antiretroviral treatment-naive HIV-1-infected adults: La Francilienne. (Record no. 12203612)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02223 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514050618.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200211s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1525-4135 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/00126334-200210010-00008 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | de Truchis, Pierre |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20021114 |
245 00 - TITLE STATEMENT | |
Title | Efficacy and safety of a quadruple combination Combivir + abacavir + efavirenz regimen in antiretroviral treatment-naive HIV-1-infected adults: La Francilienne. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of acquired immune deficiency syndromes (1999) |
Date of publication, distribution, etc. | Oct 2002 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 178-82 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alkynes |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-HIV Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiretroviral Therapy, Highly Active |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzoxazines |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CD4 Lymphocyte Count |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CD4-Positive T-Lymphocytes |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclopropanes |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dideoxynucleosides |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Combinations |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | France |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Protease Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV-1 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lamivudine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxazines |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pilot Projects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | RNA, Viral |
General subdivision | analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Reverse Transcriptase Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Viral Load |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Zidovudine |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Force, Gilles |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Welker, Yves |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mechali, Denis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pulik, Marc |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chemlal, Kadoudja |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rouveix, Elisabeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Devidas, Alain |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Praindhui, Danielle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mamet, Jean-Philippe |
773 0# - HOST ITEM ENTRY | |
Title | Journal of acquired immune deficiency syndromes (1999) |
Related parts | vol. 31 |
-- | no. 2 |
-- | p. 178-82 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/00126334-200210010-00008">https://doi.org/10.1097/00126334-200210010-00008</a> |
Public note | Available from publisher's website |
No items available.